The factors that impact on the psychological adjustment of patients undergoing haemopoietic stem cell transplantation (HSCT) have been of significant research interest. In particular, patients' experience of anxiety, depression and distress post transplantation, [1] [2] [3] has received considerable research attention. However, fewer studies have examined the experience of post-traumatic stress disorder (PTSD) symptoms following HSCT. 4 According to Ehlers and Clark's cognitive model of PTSD, individuals develop a persistent post-traumatic stress response if they process the traumatic event in a manner that leads to a sense of serious current threat. 5 Specific factors that may impact on appraisal of the trauma and its consequences include characteristics of the trauma and sequelae, as well as individuals' prior experiences and beliefs. 5 Although poorer physical functioning has been associated with more severe PTSD symptoms, 6 the relationships between trauma symptoms and medical factors such as disease stage and transplant type have been less consistent across studies. 4 Similarly, with respect to socio-demographic factors, studies have generally demonstrated unequivocal relationships between age, gender and marital status and trauma symptom severity. 4 The influence of personality-related factors on PTSD symptom severity in HSCT patients has been less well-researched. One such factor is sense of coherence (SOC). SOC was defined as a dispositional orientation that reflects the extent to which an individual believes that stimuli encountered are comprehensible, manageable and meaningful. 7 Thus, individuals with higher SOC may manage a stressful treatment procedure more effectively, leading to less psychopathology following treatment. Despite evidence suggesting that lower SOC was associated with more severe HSCT-specific emotional distress 8 and depression, 9 few studies have examined the influence of SOC on PTSD symptoms. Results of these studies have been mixed. 10, 11 The present study aimed to examine the severity of PTSD symptoms at 2-3 weeks and 3 months post transplant and whether medical/physical (that is, disease status, transplant type and physical functioning) and socio-demographic (that is, gender, age and relationship status) factors, and SOC were associated with PTSD symptom severity. Data regarding depression, anxiety and quality of life have been reported in a previous publication. Bivariate Pearson's correlations were conducted to assess the relationships between trauma domains and demographic, medical and psychosocial factors. Linear mixed-effect random intercept models were conducted to assess the changes over time in hyperarousal, intrusion and avoidance symptoms. An alpha level of 0.05 was used for analyses.
At pre-transplant, patients were on average 51.13 years Table 1 . Clinical levels of PTSD symptoms (score of ⩾ 33) 12 were reported by 26% of patients at 2-3 weeks post transplant and 10% at 3 months post transplant. When conducting the linear mixed-model analyses to assess change in trauma over time, the goodness-of-fit was improved through inclusion of gender and gender-time interaction as fixed effects. Hyperarousal symptoms reduced significantly from 2-3 weeks to 3 months post transplant (P = 0.003), with no change in avoidance or intrusion symptoms. A significant gender-time interaction was also evident for hyperarousal symptoms (P = 0.04). Female patients showed more severe symptoms compared with males at 2-3 weeks but not at 3 months post transplant.
The correlations between trauma symptoms and the assessed factors are presented in Table 2 . Age at transplant, days since diagnosis and transplant type were not correlated with trauma symptoms at either follow-up. More severe somatic symptoms and poorer physical well-being were associated with higher avoidance, intrusion and hyperarousal at both follow-up points. At 2-3 weeks post transplant, female gender was associated with higher hyperarousal and intrusion scores and lower SOC was associated with higher hyperarousal scores. At 3 months post transplant, having active disease was associated with higher hyperarousal scores, while being in a relationship before transplantation was correlated with lower intrusion scores.
While the percentage of patients experiencing clinical levels of trauma at 3 months post transplant was consistent with previous studies, 10 the percentage at 2-3 weeks post transplant was notably higher. The experience of PTSD symptoms is more common in the initial period following a traumatic event, as it is likely that patients had not yet adequately appraised the traumatic event. 5 Given that most patients in our study were in hospital at the first follow-up, a sense of threat is likely to be imminent, even though the transplantation process had already occurred. The experience of a traumatic experience such as the HSCT differs from that of a more discrete event. The trauma sequelae occur over an extended period of time following HSCT. The period of trauma appraisal (perceived threat to life) may therefore be prolonged, thus delaying psychological recovery. 10 The strongest correlates of trauma symptoms were the severity of somatic symptoms and impairments in physical well-being. These results are consistent with Ehlers and Clark's model that suggests that trauma sequelae may exacerbate an individual's negative appraisal of the trauma. 5 Although physical well-being is expected to improve gradually as patients recover, the experience of acute impairment in the initial stages may be interpreted as a sign of an impending deterioration and a permanent negative change in life. 5 Such negative appraisals may therefore exacerbate PTSD symptoms.
Female patients reported more severe trauma symptoms than males at 2-3 weeks post transplant, but not at the 3-month follow-up. It has been suggested that female HSCT patients may be less likely to express anxiety to avoid overburdening caregivers, thus resulting in intrusive stress responses as feelings become internalised. 13 Furthermore, in the present study, most patients were still in hospital and experiencing treatment-related complications at 2-3 weeks post transplant. It is possible that female patients perceive disconnection from other care-giving or social roles, thus exacerbating how their medical situation and encountered challenges were appraised.
Consistent with the cognitive model of PTSD 5 patients experiencing active disease pre-transplantation may perceive the transplant as posing a higher degree of threat and increasing vulnerability to PTSD symptoms. In contrast, being in a relationship may protect against distress, with social interactions aiding in the cognitive processing of the traumatic event as individuals discuss their treatment experience with supportive persons, rather than adopting avoidant coping.
14 Nevertheless, interpretations based on current findings are limited given that social support was not explicitly assessed.
In general, patients with higher SOC experienced fewer intrusion and hyperarousal symptoms, although only the relationship between SOC and hyperarousal at 2-3 weeks post transplant was statistically significant. Given Antonovsky's conceptualisation of SOC 15 patients who have a higher SOC are likely to possess a better understanding of the treatment process, have adequate resources to manage their illness, and believe that it is worthwhile to engage in overcoming challenges encountered during treatment. This may better equip them to process the traumatic treatment experience and integrate the trauma memory into existing or new mental schema. The current findings indicate, however, that the relationship between SOC and PTSD symptoms may be weaker than that between SOC and depressive and anxiety symptoms post HSCT. 9 Further research is needed to confirm these findings.
The levels of trauma present in HSCT patients in the early period post-transplantation suggest the need for early identification of individuals vulnerable to experiencing PTSD symptoms. Being female, having active disease, being single or experiencing a high level of physical impairment, each increased severity of PTSD symptoms. Thus, assessing for these factors in pre-transplant assessments may be beneficial. This would allow for the provision of follow-up support to particularly vulnerable patients. The support may encompass referrals to psychological services and/or provision of minimal contact interventions (for example, self-help material and e-therapy program). Furthermore, it may be important to increase patients awareness through psychoeducation that PTSD symptoms occurring shortly after treatment are common reactions and will improve over time for most patients. It is important to note this study's limitations. For example, only 45% of the available HSCT patient cohort participated in the study. Furthermore, one-third of participants did not complete the 3-month assessment. As severely ill patients were less likely to complete the study, study findings may not adequately capture their experience. Nevertheless, this research adds to the literature by prospectively examining the influence of pre-transplant factors on post-transplant trauma symptoms. Future research would benefit from assessing the mechanisms through which sociodemographic factors and SOC influences the presentation of trauma symptoms. This would allow clarification of whether factors such as coping and social support mediate the observed relationships, so that early intervention and assertive follow-up can be provided to patients at risk of developing chronic trauma symptoms.
